The Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare, but severe" suspected side-effects among vaccinated people in other countries.
The Indonesian Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
PortugueseDirectorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as aprecaution following reports of "rare,butserious" side-effects among vaccinated people.
The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaitingWHOreviewamidst reports of bloodclotcases amongst vaccinated peopleinseveralEuropeancountries.
Slovenia suspends the use of the Oxford–AstraZeneca vaccine as aprecaution following reports of blood clot cases among vaccinated people.
ThePortugueseDirectorate-GeneralofHealthtemporarilysuspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare,butserious" side-effects among vaccinated people.
Latvianhealthauthorities temporarilysuspends temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of bloodclot issues among vaccinated people.
Latvian health authorities temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
Latvian health authorities temporarily suspend the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
TheAndorran government announces the suspensionofthe use of the Oxford–AstraZeneca vaccine as of March16.
The Ministry ofHealthtemporarily suspends the use of the Oxford–AstraZeneca vaccine whileawaitingaWHOreviewamidstreportsof casesofbloodclotsinvaccinatedpeoplefromseveralEuropeancountries.
The Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precautionfollowing reports of "rare, butsevere"suspected side-effects among vaccinated people in other countries.